Hollis172172. Hollis C, Pennant M, Cuenca J, Glazebrook C, Kendall T, Whittington C, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. Health Technol Assess. 2016;20:1-450.
|
Antipsychotics are effective in reducing tics in TS patients (meta-analysis) |
Zheng173173. Zheng W, Li XB, Xiang YQ, Zhong BL, Chiu HF, Ungvari GS, et al. Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis. Hum Psychopharmacol. 2016;31:11-8.
|
Aripiprazole as effective as haloperidol or tiapride in reducing tics in TS patients (meta-analysis) |
Van Ameringen174174. Van Ameringen M, Mancini C, Patterson B, Bennett M, Oakman J. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;71:1336-43.
|
Olanzapine as an effective treatment in TTM |
Howard175175. Howard AK, Krishnamoorthy A, Leavitt BR, Raymond LA, Weissman CR. Treatment of Huntington disease and comorbid trichotillomania with Aripiprazole. J Neuropsychiatry Clin Neurosci. 2015;27:e211-2.
|
Aripiprazole as an effective treatment of TTM in a patient suffering from Huntington disease (case report) |
Yasui-Furukori176176. Yasui-Furukori N, Kaneko S. The efficacy of low-dose aripiprazole treatment for trichotillomania. Clin Neuropharmacol. 2011;34:258-9.
|
Aripiprazole as an effective treatment of TTM (case report) |
White177177. White MP, Koran LM. Open-label trial of aripiprazole in the treatment of trichotillomania. J Clin Psychopharmacol. 2011;31:503-6.
|
Aripiprazole as an effective treatment of TTM |
Virit178178. Virit O, Selek S, Savas HA, Kokacya H. Improvement of restless legs syndrome and trichotillomania with aripiprazole. J Clin Pharm Ther. 2009;34:723-5.
|
Aripiprazole as an effective treatment of TTM (case report) |
Jefferys179179. Jefferys D, Burrows G. Reversal of trichotillomania with aripiprazole. Depress Anxiety. 2008;25:E37-40.
|
Aripiprazole as an effective treatment of TTM (case report) |
Van Ameringen180180. Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord. 1999;56:219-26.
|
Haloperidol as an effective treatment of TTM (in nine patients, no control group) |
Crescente Jr.181181. Crescente Junior JA, Guzman CS, Tavares H. Quetiapine for the treatment of trichotillomania. Rev Bras Psiquiatr. 2008;30:402.
|
Efficacy of quetiapine in TTM (case report) |
Khouzam182182. Khouzam HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry. 2002;65:261-70.
|
Efficacy of quetiapine in TTM (case report) |
Stewart183183. Stewart RS, Nejtek VA. An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2003;64:49-52.
|
Olanzapine as an effective treatment in TTM |
Liu184184. Liu Y, Ni H, Wang C, Li L, Cheng Z, Weng Z. Effectiveness and tolerability of Aripiprazole in children and adolescents with Tourette's disorder: a meta-analysis. J Child Adolesc Psychopharmacol. 2016;26:436-41.
|
Aripiprazole as an effective treatment in TS (meta-analysis) |
Oravecz185185. Oravecz R, Stuhec M. Trichotillomania successfully treated with risperidone and naltrexone: a geriatric case report. J Am Med Dir Assoc. 2014;15:301-2.
|
Risperidone as an effective treatment of TTM (case report) |
Mancini186186. Mancini C, Van Ameringen M, Patterson B, Simpson W, Truong C. Trichotillomania in youth: a retrospective case series. Depress Anxiety. 2009;26:661-5.
|
Antipsychotics as an effective treatment in TTM (case series) |
Ashton187187. Ashton AK. Olanzapine augmentation for trichotillomania. Am J Psychiatry. 2001;158:1929-30.
|
Olanzapine as an effective treatment in TTM (four cases) |
Senturk188188. Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics. 2002;43:429-30.
|
Risperidone as an effective treatment of TTM (case report) |
Srivastava189189. Srivastava RK, Sharma S, Tiwari N, Saluja B. Olanzapine augmentation of fluoxetine in trichotillomania: two cases. Aust N Z J Psychiatry. 2005;39:112-3.
|
Olanzapine as an effective treatment of TTM (two cases) |
Potenza190190. Potenza MN, Wasylink S, Epperson CN, McDougle CJ. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania. Am J Psychiatry. 1998;155:1299-300.
|
Olanzapine as an effective treatment in TTM (case report) |
Epperson191191. Epperson CN, Fasula D, Wasylink S, Price LH, McDougle CJ. Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. J Child Adolesc Psychopharmacol. 1999;9:43-9.
|
Risperidone as an effective treatment of TTM (three cases) |
Gabriel192192. Gabriel A. A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry. 2001;46:285-6.
|
Risperidone as an effective treatment of TTM (case report) |
Ghaziuddin193193. Ghaziuddin M, Tsai LY, Ghaziuddin N. Brief report: haloperidol treatment of trichotillomania in a boy with autism and mental retardation. J Autism Dev Disord. 1991;21:365-71.
|
Haloperidol as an effective treatment of TTM (case report) |
Stein194194. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry. 1992;53:123-6.
|
Pimozide as an effective treatment of TTM (in six cases out of seven) |
Pathak195195. Pathak S, Danielyan A, Kowatch RA. Successful treatment of trichotillomania with olanzapine augmentation in an adolescent. J Child Adolesc Psychopharmacol. 2004;14:153-4.
|
Olanzapine as an effective treatment of TTM (case report) |
Rothbart196196. Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2013:CD007662.
|
No efficacy of SSRI in TTM (Cochrane review) |
Rothbart197197. Rothbart R, Stein DJ. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. Expert Opin Pharmacother. 2014;15:2709-19.
|
No efficacy of SSRI in TTM (Cochrane review) |
Bloch198198. Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, et al. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry. 2007;62:839-46.
|
No efficacy of SSRI but efficacy of clomipramine in TTM (meta-analysis) |
Christenson199199. Christenson GA, Mackenzie TB, Mitchell JE, Callies AL. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991;148:1566-71.
|
No efficacy of fluoxetine in TTM |
Streichenwein200200. Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry. 1995;152:1192-6.
|
No efficacy of fluoxetine in TTM |
Van Minnen201201. van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand I, Hendriks GJ. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry. 2003;60:517-22.
|
No efficacy of fluoxetine in TTM |
Scahill202202. Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol. 1997;7:75-85.
|
No efficacy of fluoxetine in TS |
Issari203203. Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. J Clin Psychiatry. 2016;77:e605-11.
|
Efficacy of SSRI in OCD (meta-analysis) |
Romanelli204204. Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety. 2014;31:641-52.
|
Efficacy of SRI in OCD (meta-analysis) |
Bloch205205. Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry. 2010;15:850-5.
|
Efficacy of SSRI in OCD (meta-analysis) |
Soomro206206. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008:CD001765.
|
Efficacy of SSRI in OCD (meta-analysis) |
Ivarsson207207. Ivarsson T, Skarphedinsson G, Kornor H, Axelsdottir B, Biedilae S, Heyman I, et al. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis. Psychiatry Res. 2015;227:93-103.
|
Efficacy of SRI in OCD (meta-analysis) |
McGuire208208. McGuire JF, Piacentini J, Lewin AB, Brennan EA, Murphy TK, Storch EA. A Meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: moderators of treatment efficacy, response, and remission. Depress Anxiety. 2015;32:580-93.
|
Efficacy of SRI in OCD (meta-analysis) |
Stein209209. Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995;10:11-8.
|
Efficacy of SRI in OCD (meta-analysis) |
Sanchez-Meca210210. Sanchez-Meca J, Rosa-Alcazar AI, Iniesta-Sepulveda M, Rosa-Alcazar A. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis. J Anxiety Disord. 2014;28:31-44.
|
Efficacy of SRI in OCD (meta-analysis) |
Geller212212. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003;160:1919-28.
|
Efficacy of SSRI in OCD (meta-analysis) |
Piccinelli213213. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry. 1995;166:424-43.
|
Efficacy of SRI in OCD (meta-analysis) |
Varigonda214214. Varigonda AL, Jakubovski E, Bloch MH. Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and Clomipramine in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2016;55:851-9 e2.
|
Efficacy of SSRI in OCD (meta-analysis) |
McGuire215215. McGuire JF, Ung D, Selles RR, Rahman O, Lewin AB, Murphy TK, et al. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. J Psychiatr Res. 2014;58:76-83.
|
Efficacy of SRI in TTM (meta-analysis) |
Caine216216. Caine ED, Polinsky RJ, Ebert MH, Rapoport JL, Mikkelsen EJ. Trial of chlorimipramine and desipramine for Gilles de la Tourette syndrome. Ann Neurol. 1979;5:305-6.
|
No efficacy of SRI TS |
Bloch217217. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622-32.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Veale218218. Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:317.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Dold219219. Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol. 2013;16:557-74.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Dold220220. Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol. 2015;18. pii: pyv047. doi: http://10.1093/ijnp/pyv047
http://10.1093/ijnp/pyv047...
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Skapinakis221221. Skapinakis P, Papatheodorou T, Mavreas V. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol. 2007;17:79-93.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Maher AR222222. Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306:1359-69.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |
Fineberg223223. Fineberg NA, Stein DJ, Premkumar P, Carey P, Sivakumaran T, Vythilingum B, et al. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials. Int Clin Psychopharmacol. 2006;21:337-43.
|
Efficacy of antipsychotics in OCD as an augmentation treatment (meta-analysis) |